GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹196 Cr | ₹146 Cr | ₹137 Cr | - | - |
What is the latest Long Term Provisions ratio of GLAND PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹196 Cr |
| Mar2025 | ₹146 Cr |
| Mar2024 | ₹137 Cr |
| Mar2023 | - |
| Mar2022 | - |
How is Long Term Provisions of GLAND PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹196 Cr | 34.01 | |
| Mar2025 | ₹146 Cr | 6.40 | |
| Mar2024 | ₹137 Cr | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | - | |
Compare Long Term Provisions of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹46,536.6 Cr | -3% | 18.6% | 43% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -3% |
18.6% |
43% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses